Top

Published in:

01-11-2021 | Ovarian Cancer | ASO Author Reflections

ASO Author Reflections: Disparities in Access to Cytoreductive Surgery

Authors: Ellen M. Goldberg, MPH, Oliver S. Eng, MD

Published in: Annals of Surgical Oncology | Issue 12/2021

Excerpt

Cytoreductive surgery (CRS) for ovarian cancer with peritoneal metastases (OPM) has been established as a beneficial treatment since the 1980s. 1 Racial disparities in access to advanced treatments for ovarian cancer are well documented; Black patients are less likely to receive the same standard of care as White patients, which is reflected in differences in disease-specific and all-cause mortality rates. 2 Alternatively, CRS for colorectal cancer with peritoneal metastases (CRPM) has only recently emerged as an acceptable modality of care and requires significant institutional expertise and resources. 3, 4 How do barriers to accessing CRS compare between these histologies? …

Halkia E, Spiliotis J, Sugarbaker P. Diagnosis and management of peritoneal metastases from ovarian cancer. Gastroenterol Res Pract. doi:https://doi.org/10.1155/2012/541842

Bristow RE, Chang J, Ziogas A, Campos B, Chavez LR, Anton-Culver H. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines. Obstet Gynecol. 2015;125(4):833–42. https://doi.org/10.1097/AOG.0000000000000643.CrossRefPubMedPubMedCentral

Quénet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256–66. https://doi.org/10.1016/S1470-2045(20)30599-4.CrossRefPubMed

Kusamura S, González-Moreno S, Nizri E, et al. Learning curve, training program, and monitorization of surgical performance of peritoneal surface malignancies centers. Surg Oncol Clin N Am. 2018;27(3):507–17. https://doi.org/10.1016/j.soc.2018.02.009.CrossRefPubMed

Goldberg EM, Berger Y, Sood D, et al. Differences in sociodemographic disparities between patients undergoing surgery for advanced colorectal or ovarian cancer. Ann Surg Oncol. Published online May 6, 2021. doi:https://doi.org/10.1245/s10434-021-10086-y

Phelan JC, Link BG. Is racism a fundamental cause of inequalities in health? Annu Rev Sociol. 2015;41(1):311–30. https://doi.org/10.1146/annurev-soc-073014-112305.CrossRef

Rubin MS, Clouston S, Link BG. A fundamental cause approach to the study of disparities in lung cancer and pancreatic cancer mortality in the United States. Soc Sci Med. 2014;100:54–61. https://doi.org/10.1016/j.socscimed.2013.10.026.CrossRefPubMed

Title: ASO Author Reflections: Disparities in Access to Cytoreductive Surgery
Authors: Ellen M. Goldberg, MPH
Oliver S. Eng, MD
Publication date: 01-11-2021
Publisher: Springer International Publishing
Keywords: Ovarian Cancer
Ovarian Cancer
Published in: Annals of Surgical Oncology / Issue 12/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-021-10207-7

2024 ASCO Annual Meeting

Springer Medicine

ASO Author Reflections: Disparities in Access to Cytoreductive Surgery

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2021

Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center Experience

Clinical Significance of Serum Squamous Cell Carcinoma Antigen for Patients with Recurrent Esophageal Squamous Cell Carcinoma

ASO Author Reflections: The Broad Impact of the Margin Consensus Guidelines for Breast-Conserving Surgery in DCIS

ASO Author Reflections: A Genomic Blood Test (NETest) that Informs you if the Patient has a Recurrence at the First Postoperative Visit

ASO Author Reflections: Immunotherapy in Rectal Cancer Illusion or Nirvana

Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal Tumor